Close
Open Nav
Participating Companies

Below is a representative list of participating companies for the 2019 CEO & Investor Conference:

2020Gene
Abcuro
AbMax Biotechnology 
AbPro
Acme 
Acquist Therapeutics
Actinium Pharmaceuticals
Adocia
AdventHealth
Affigen
Affimed N.V.
Agile Therapeutics
AIMM Therapeutics
AiVita Biomedical
Alliance for Aging Research
Alliance Global Partners
Alloy Therapeutics
Alnylam Pharmaceuticals
Alpha Cancer Technologies
Altimmune
American Gene Technologies International
American Laboratory Trading (ALT)
Amicus Therapeutics
Amplyx Pharmaceuticals
Anavex Life Sciences Corp.
AnGes
Anima Biotech
Antengene Corporation Co.
Aon Risk Solutions
Aptorum Group Limited
Aquestive Therapeutics
Arbor Pharmaceuticals
Arch Therapeutics
Arcturus Therapeutics
Ascletis Pharma
Aspect Biosystems
Astellas Pharma US
Atomwise
aTyr Pharma
AUM
Austrade
AveXis
Avid Bioservices
Azitra
Balinbac Therapeutics
Berlin Partner GmbH
BIA
Bioasis Technologies
Biocom
BioMarker Strategies
Bio-Path Holdings
Biotechgate/Venture Valuation
BioVaxys 
BioVersys AG
Bioxceed Innovation Hub
BioXcel Therapeutics
Blaise Group International
Bloom Science
BMO Capital Markets
Boehringer Ingelheim
Bolder Biotechnology
Brainstorm Cell Therapeutics
Brandenburg Invest
Bristol-Myers Squibb Company
Business Insider
Caladrius Biosciences
Cambridge Gene Therapy Limited
Canalis Pharmaceuticals
Cancer Prevention Pharmaceutical
Cancer Research & Biostatistics (CRAB)
Cantor Fitzgerald & Company
CARB-X
Carmell Therapeutics
CASI Pharmaceuticals
Catalyst Biosciences
Catalyst Pharmaceuticals
Celgene Corporation
Cell Care Therapeutics
Cellectar Biosciences
CEL-SCI Corporation
Center for Biocatalysis and Bioprocessing - University of Iowa
Cesca Therapeutics
CG Pharmaceuticals
Children's Tumor Foundation
City of Philadelphia
Clarivate Analytics
Clinical Network Services (CNS) 
co.don AG
CohBar
Columbia University
Congenica
Consulate General of Lithuania
ConSynance Therapeutics
ContraFect Corporation
Cortellis / Calrivate Analytics
Cowen and Company
Cox Biosciences
CSPC Pharma
Cue Biopharma
Curis
Cyclacel Pharmaceuticals
Cytodyn
Cytori Therapeutics
CytoSorbents
Daré Bioscience
Deerfield Management Company LP
Delaware Innovation Space
DiaMedica Therapeutics
Dyadic International
Editas Medicine
EIP Pharma
Eli Lilly and Company
Eloxx Pharmaceuticals
ELS Solutions
EnGeneIC
Entasis Therapeutics
Entera Bio 
EpiVax Oncology
E-Scape Bio
Espero BioPharma
Evaluate
EVOQ Therapeutics
Exicure
EyeGate Pharmaceuticals
Femtobiomed
Fibrocell Science
Formula Pharmaceuticals
Foundation for Prader Willi Research
FreeMind Group
Fulcrum Therapeutics
Galimedix Therapeutics
Gedeon Richter Plc
Genes2me
Gila Therapeutics
Global Business Reports
Government of Ontario
Government of Victoria
Greater Zurich Area Ag
Greek Trade Office at the Consulate General of Greece in New York
Greenwich LifeSciences
H.C. Wainwright & Company
Heat Biologics
Helix BioPharma Corp.
Hemostemix
Hitech Health
I-APCELL
ICON Plc.
IDA Ireland
ILLUSTRATUM
Imcyse
ImmBio
Immunic Therapeutics
Immunicum AB
ImmunoMet Therapeutics
Immunomic Therapeutics
ImmunoPrecise Antibodies
ImmunSYS
Impact Therapeutics
IMV
InCarda Therapeutics
Indegene
Infinity Pharmaceuticals
InMed Pharmaceuticals
INmune Bio
Intensity Therapeutics
InteRNA Technologies B.V.
Interpace Diagnostics Group
Invirsa
IO Biosciences
Iota Biosciences
iQure Pharma 
IQVIA
Japan External Trade Organization (JETRO)
JP Morgan Securities
Kallyope

Kelun Pharmaceuticals 
Kitov Pharmaceuticals
Kleo Pharmaceuticals
Knopp Biosciences LLC
Korea Drug Development Fund (KDDF)
KOTRA
Landos Biopharma
Lantern Pharma
LaunchBio
LaunchBio, Inc.
Lead Pharma
Leading BioSciences
LifeEDIT
Longeveron
Lumme
Lung Therapeutics
Lyndra
Lyndra Therapeutics
Lyonbiopole
MacDougall
Marcum
Marker Therapeutics, Inc.
Maryland Life Sciences
MaxCyte
Medical Developments International Limited
Medicenna Therapeutics
MeiraGTx
Melinta Therapeutics, Inc.
MetrioPharm AG
Mirum Pharmaceuticals
Mitsubishi Tanabe Pharma Corporation
Morrison & Foerster
Muscular Dystrophy Association (MDA)
NanOlogy
NanoViricides
National Health Council
National Venture Capital Association
NDA Group
Nemus Bioscience
NeuroRx
NeuroTrauma Sciences
Neurotrope
New Enterprise Associates (NEA)
New Harbor Venture Partners
New Orleans Business Alliance
New York BIO
Newcastle University
Newron Pharmaceuticals
NewYorkBIO
NicOx
Nikon Instruments
NoNO
Novos Growth Partners
NS Pharma
Nucleus Network
OcuMedic
OncoCyte Corporation
Oncolytics Biotech
Onconova Therapeutics
OncoSec Medical
Opiant Pharmaceuticals
Oramed Pharmaceuticals
Orpheris
Oryzon Genomics, S.A.
Otsuka Pharmaceutical Co.
OxSonics Therapeutics
Oxurion NV
Oyster Point Pharmaceuticals
PAION AG
Panorama Medicine
Paras Biopharmaceuticals Finland Oy
PathMaker Neurosystems 
pH Pharma
PharmaDirections
Phio Pharmaceuticals Corporation
Pipeline Therapeutics
Piper Jaffray & Co.
POP Biotechnologies
Precision NanoSystems
Proactiveinvestors North America
Probiodrug AG
Procarta Biosystems
Propanc Biopharma
Proteina Co.
ProterixBio
Q BioMed
Rapafusyn Pharmaceuticals
Recardio
Redhill Biopharma
ReForm Biologics
Reglagene
Regrow Biosciences
Relmada Therapeutics
Reneo Pharmaceuticals
Resverlogix Corporation
Reviva Pharmaceuticals, Inc.
Rhythm Biosciences
Rockwell Medical
ROTH Capital Partners
Salarius Pharmaceuticals
Samyang Biopharmaceuticals Corporation
Sanofi
Sapience Therapeutics
SATOR Therapeutics
Schonfeld Strategic
Scilex Pharmaceuticals
Scynexis
Sea4Us
Second Genome
Select Greater Philadelphia
Sellas Life Sciences Group
SEngine Precision Medicine
Sensei Biotherapeutics
Senti Biosciences
Seraxis
Serina Therapeutics
Servier
ShareVault
SIGA Technologies
Silk Road Therapeutics
Silurian Pharmaceuticals
Sirnaomics
SMP Communications
Sofinnova Ventures
Spark Therapeutics
SpinalCyte
Summit Therapeutics 
Sutro Biopharma
Swansea University
Swiss Business Hub USA
SynDevRx
Synlogic
Synthetic Biologics
T1D Exchange
Tarveda Therapeutics
Tenax Therapeutics
The Channel Group
The Cure BV
The Money Channel NYC
The Trout Group 
The University of Chicago
Tiberend Strategic Advisors
Timmune Biotech
Tokyo Stock Exchange
TONIX Pharmaceuticals
Torreya
Trevena
Trican Biotechnology Co.
Triumvira Immunologics USA
TrovaGene
UCB Ventures
Unicycive Therapeutics
University of Texas, MD Anderson Cancer Center
Urigen Pharmaceuticals
Valentech Pharma
Vallon Pharma
VBI Vaccines
VenatoRx Pharmaceuticals
Verona Pharma
Verseon Corporation
Vida Strategic Partners
VistaGen Therapeutics
Vital Transformation
VLP Therapeutics
VWR International
Vyome Therapeutics
Vyriad
Wells Fargo
WilmerHale
WuXi NextCODE
Yiviva / Yale
Zafgen
Zynerba Pharmaceuticals

 
*as of 2/6/2019